TROG_2014_ASM-program

TROG 201426th ANNUAL SCIENTIFIC MEETING 20TROG 201421 26th ANNUAL SCIENTIFIC MEETINGTHURSDAY 3rd APRIL 20148.55 - 10.05am Prostate Chair:S Porceddu8.55am9.00am9.15am9.30am03.06 (TOAD): A collaborative randomised phase III trial:The timing of intervention with androgen deprivation inprostate cancer patients with a rising PSA (Closed)96.01: Randomised trial investigating the effectivenessof different durations of maximal androgen deprivationprior to and during definitive radiation therapy forlocally advanced carcinoma of the prostate (Closed)03.04 (RADAR): A collaborative randomised phase III trial:The timing of intervention with androgen deprivation inprostate cancer patients with a rising PSA (Closed)08.03 (RAVES): Radiotherapy – Adjuvant Versus EarlySalvage (Open)G DuchesneJ DenhamJ DenhamK Wiltshire9.35am 08.03 (RAVES DA): Decision Aid Study P Sundaresan9.40amGuest Speaker: Proscare: “A psychological care modelfor men with prostate cancer”S Chambers10.05 - 11.00am Head & Neck Chair:G Duchesne10.05am10.10am10.20am10.25am10.30am11.00 - 11.30am Morning Tea12.03 (EAT): Eating As Treatment - An RCT ofpsychological training for dieticians to reducemalnutrition and depression in Head and Neck (Open)07.03 (RadioHUM): Radiotherapy with Humidification inhead and neck cancer (Closed)07.04: A Phase I/II study of cetuximab, carboplatin andradiotherapy for patients with locally advanced Headand Neck Squamous Cell Carcinoma (Closed)12.01 (HPV): A randomised trial of radiation withcetuximab or weekly cisplatin in low risk locoregionallyadvanced HPV-associated oropharyngeal cancer (Open)Guest Speaker: The Clinical Trials Portfolio of the NCIHead and Neck Steering CommitteeC WrattenA MacannJ CorryD RischinJ CorryD Brizel11.30 - 12.10pm Lymphoma Chair:F Hegi-Johnson11.30am99.03: A Randomised Multicentre Trial Of InvolvedField Radiotherapy Versus Involved Field RadiotherapyPlus Chemotherapy in combination with Rituximab(MabThera®) For Stage I – II Low Grade FollicularLymphoma (Closed)TBC11.40am11.45am05.02: A prospective single arm trial of involved fieldradiotherapy alone for stage I-II low grade non-gastricmarginal zone lymphoma (Open)01.02: Phase II study of Idarubicin based combinedmodality therapy in primary central nervous systemlymphoma (Closed)TBCP O’Brien11.55am “Grant Successes - Preparation or Luck” T Leong12.10 - 12.50pm New Proposals: Category B Chair:F Foroudi12.10pm12.20pm12.30pm12.40pm12.50 - 2.00pm LunchA randomised trial of regional nodal irradiationfollowing sentinel lymph node biopsy alone (LeadGroup: NCIC)ENZARAD: Randomised phase III trial of radiation plusandrogen deprivation therapy with or without enzalutamidefor high-risk, clinically localised, prostate cancer(Lead Group: ANZUP)Phase III study of observation vs adjuvant RT forSimpson